NCT07413666PHASE1RecruitingAccepts Healthy Volunteers
A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
Centessa Pharmaceuticals (UK) Limited
Start Date
2/25/2026
Completion Date
6/30/2027
Summary
Characterize the safety, tolerability and pharmacokinetics of ORX489 following single and multiple doses.
Eligibility Criteria
Age Range: 18 years to 60 years
Inclusion Criteria:
* Healthy males or females as determined by assessments at the Screening Visit.
* For Parts A, B, C, and D: Participants must be at least 18 years of age and no more than 60 years of age at the Screening
Exclusion Criteria:
* Presence of significant cardiac, pulmonary, gastrointestinal, hepatic, renal, hematological, malignancy, endocrine, neurological, or psychiatric disease, as determined by medical history, physical examination, and screening investigations.
* History of seizure disorder, any other condition that increases the risk of seizure
* Has a clinically significant sleep disorder, including insomnia or sleep apnea
Interventions
DRUG
ORX489 Tablets
OTHER
Placebo Tablets
Conditions
Healthy Adult Male and Female Volunteers
Locations
Celerion
Lincoln, Nebraska 68502
United States